Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 887-890, February 15, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ralston, S. L.
Right arrow Articles by Baird, W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ralston, S. L.
Right arrow Articles by Baird, W. M.

The Potent Carcinogen Dibenzo[a,l]pyrene Is Metabolically Activated to Fjord-Region 11,12-Diol 13,14-Epoxides in Human Mammary Carcinoma MCF-7 Cell Cultures1

Sherry L. Ralston, Hudson H. S. Lau2, Albrecht Seidel, Andreas Luch, Karl L. Platt and William M. Baird3

Department of Medicinal Chemistry and Pharmacognosy, Purdue University, West Lafayette, Indiana 47907 [S. L. R., H. H. S. L., W. M. B.], and Institute of Toxicology, University of Mainz, Obere Zahlbacher Str. 67, D-55131 Mainz, Germany [A. S., A. L., K. L. P]

3 To whom requests for reprints should be addressed, at Department of Medicinal Chemistry, Hansen Life Sciences Research Building, Purdue University, West Lafayette, IN 47907.

Dibenzo[a,l]pyrene (DB[a,l]P), an environmental hydrocarbon and very potent carcinogen in rodent bioassays, could be activated to DNA-binding intermediates in cells through formation of three different regioisomeric bay- or fjord-region diol-epoxides or other more highly oxidized metabolites. The mechanism of metabolic activation of DB[a,l]P in the human mammary carcinoma cell line MCF-7 was elucidated by analyzing the DB[a,l]P-DNA adducts formed by [35S]phosphorothioate postlabeling, immobilized boronate chromatography, and high-performance liquid chromatography. Six DB[a,l]P-DNA adducts were detected. Comparison with those formed in cells by DB[a,l]P-11,12-diol and by reaction of DNA with syn- and anti-(benzylic hydroxyl and epoxide oxygen cis and trans, respectively) DB[a,l]P-11,12-diol-13,14-epoxide (DB[a,l]PDE) demonstrated that all DB[a,l]P-DNA adducts in MCF-7 cells were formed by these diol-epoxide isomers. Cellular DNA contained large amounts of two syn- and one anti-DB[a,l]PDE-DNA adducts and small amounts of one syn- and two anti-DB[a,l]PDE-DNA adducts. The ability of human cells to activate DB-[a,l]P to its fjord-region 11,12-diol 13,14-epoxides suggests that environmental exposure to DB[a,l]P could pose a risk for humans.

1 This work was supported by Grant CA40228 from the National Cancer Institute, Department of Health and Human Services, and by the Deutsche Forschungsgemeinschaft SFB302. S. L. R. was supported by Training Grant T32-CA09634.

2 Present Address: Monsanto Agricultural Company, Environmental Health Laboratory, St. Louis, MO 63110.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 11/ 5/93. Accepted 1/ 5/94.




This article has been cited by other articles:


Home page
Toxicol SciHome page
T. Musafia-Jeknic, B. Mahadevan, C. Pereira, and W. M. Baird
Long-Term Effects of a Standardized Complex Mixture of Urban Dust Particulate on the Metabolic Activation of Carcinogenic Polycyclic Aromatic Hydrocarbons in Human Cells in Culture
Toxicol. Sci., December 1, 2005; 88(2): 358 - 366.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-H. Yoon, A. Besaratinia, Z. Feng, M.-s. Tang, S. Amin, A. Luch, and G. P. Pfeifer
DNA Damage, Repair, and Mutation Induction by (+)-Syn and (-)-Anti-Dibenzo[a,l]Pyrene-11,12-Diol-13,14-Epoxides in Mouse Cells
Cancer Res., October 15, 2004; 64(20): 7321 - 7328.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Shimada, K. Inoue, Y. Suzuki, T. Kawai, E. Azuma, T. Nakajima, M. Shindo, K. Kurose, A. Sugie, Y. Yamagishi, et al.
Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice
Carcinogenesis, July 1, 2002; 23(7): 1199 - 1207.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
V. J. Melendez-Colon, A. Luch, A. Seidel, and W. M. Baird
Cancer initiation by polycyclic aromatic hydrocarbons results from formation of stable DNA adducts rather than apurinic sites
Carcinogenesis, October 1, 1999; 20(10): 1885 - 1891.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Luch, S. Kishiyama, A. Seidel, J. Doehmer, H. Greim, and W. M. Baird
The K-Region trans-8,9-Diol Does Not Significantly Contribute as an Intermediate in the Metabolic Activation of Dibenzo[a,l]pyrene to DNA-binding Metabolites by Human Cytochrome P450 1A1 or 1B1
Cancer Res., September 1, 1999; 59(18): 4603 - 4609.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. M. Arif, W. A. Smith, and R. C. Gupta
DNA adduct formation and persistence in rat tissues following exposure to the mammary carcinogen dibenzo[a,l]pyrene
Carcinogenesis, June 1, 1999; 20(6): 1147 - 1150.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. J. Melendez-Colon, A. Luch, A. Seidel, and W. M. Baird
Comparison of Cytochrome P450- and Peroxidase-dependent Metabolic Activation of the Potent Carcinogen Dibenzo[a,l]pyrene in Human Cell Lines: Formation of Stable DNA Adducts and Absence of a Detectable Increase in Apurinic Sites
Cancer Res., April 1, 1999; 59(7): 1412 - 1416.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. J. Melendez-Colon, C. A. Smith, A. Seidel, A. Luch, K. L. Platt, and W. M. Baird
Formation of stable adducts and absence of depurinating DNA adducts in cells and DNA treated with the potent carcinogen dibenzo[a,l]pyrene or its diol epoxides
PNAS, December 9, 1997; 94(25): 13542 - 13547.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.